Willard Dere
Director/Board Member at BIOMARIN PHARMACEUTICAL INC.
Net worth: 3 M $ as of 2024-04-29
Network origin in Willard Dere first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
281
| Public Company | Pharmaceuticals: Major | 281 |
| Public Company | Pharmaceuticals: Major | 186 | |
| Holding Company | Biotechnology | 60 | |
| Public Company | Biotechnology | 58 | |
University of California, Davis
54
| College/University | Other Consumer Services | 54 |
| Public Company | Biotechnology | 31 | |
| Public Company | Biotechnology | 29 | |
| Public Company | Pharmaceuticals: Major | 16 | |
The Indiana University School of Medicine
15
| College/University | Other Consumer Services | 15 |
| Subsidiary | Pharmaceuticals: Major | 11 | |
Peel Therapeutics, Inc.
 Peel Therapeutics, Inc. BiotechnologyHealth Technology Peel Therapeutics, Inc. engages as pre-clinical stage biotech that is strategically positioned at the intersection of nature and technology. The company is founded by Joshua Schiffman and Avi Schroeder in 2015 and is headquartered in Salt Lake City, UT.
5
| Private Company | Biotechnology | 5 |
Angitia Biopharmaceuticals Guangzhou Ltd.
 Angitia Biopharmaceuticals Guangzhou Ltd. BiotechnologyHealth Technology Angitia Biopharmaceuticals Guangzhou Ltd. develops therapies for musculoskeletal diseases. The company is based in Guangzhou, China. The Chinese company was founded in 2018 by Muyu Li, Hua Zhu Ke. Hua Zhu Ke has been the CEO since 2018.
3
| Holding Company | Biotechnology | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Willard Dere via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal Director/Board Member Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member Director/Board Member General Counsel Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chairman Corporate Officer/Principal Director/Board Member | |
| TESARO INC | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Business School | College/University | Corporate Officer/Principal Corporate Officer/Principal Masters Business Admin Masters Business Admin Masters Business Admin | |
| Massachusetts Institute of Technology | College/University | Director/Board Member Graduate Degree Corporate Officer/Principal Masters Business Admin Undergraduate Degree | |
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Chief Executive Officer Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Sales & Marketing General Counsel Corporate Officer/Principal Chief Executive Officer | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Executive Officer Private Equity Analyst Corporate Officer/Principal Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| TURG POIN | Pharmaceuticals: Major | Chairman Chief Executive Officer Director/Board Member | |
| Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| University of California, Berkeley | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
| ADAPTIMMUNE THERAPEUTICS PLC | Biotechnology | Director/Board Member Chairman Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Director/Board Member | |
| University of Pennsylvania | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
| SHIRE | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| AMBIT BIOSCIENCES CORP | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| Columbia Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| THERMO FISHER SCIENTIFIC | Medical Specialties | Director/Board Member Corporate Officer/Principal Director of Finance/CFO | |
Amgen Ventures LLC
 Amgen Ventures LLC Investment ManagersFinance Amgen Ventures LLC (Amgen Ventures) is a venture capital subsidiary of Amgen, Inc. founded in 2004. The firm is headquartered in Thousand Oaks, California. | Investment Managers | Chief Executive Officer Chief Operating Officer General Counsel | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Director/Board Member Director/Board Member Director/Board Member | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| RUBIUS THERAPEUTICS | Biotechnology | Founder Director/Board Member Director of Finance/CFO | |
| University of California, Los Angeles | College/University | Doctorate Degree Undergraduate Degree Corporate Officer/Principal | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| XILIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member President Corporate Officer/Principal | |
| Purdue University | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Cydan LLC
 Cydan LLC Medical DistributorsDistribution Services Cydan LLC operates as an orphan drug accelerator that identifies and de-risks programs. The firm's model evaluates programs for treating rare diseases with unmet medical need and is aimed at creating new companies to develop those therapies. The company was founded by James G. McArthur in 2013 and is headquartered in Cambridge, MA. | Medical Distributors | Chairman Director/Board Member | |
Adaptimmune Ltd.
 Adaptimmune Ltd. Medical/Nursing ServicesHealth Services Adaptimmune Ltd. develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. It utilizes the T cell to target and destroy cancerous and infected cells by using affinity T cell receptor proteins as a means of strengthening patient T cell responses. The company was founded by Bent K. Jakobsen, James Julian Noble and Helena Katrina Tayton-Martin in 2008 and is headquartered in Oxford, the United Kingdom. | Medical/Nursing Services | Chairman Director/Board Member | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree | |
| ZOSANO PHARMA CORPORATION | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Indiana University | College/University | Masters Business Admin Masters Business Admin | |
| Rensselaer Polytechnic Institute | College/University | Director/Board Member Graduate Degree | |
Research!America
 Research!America Miscellaneous Commercial ServicesCommercial Services Research!America is a lobbying firm. The non-profit company is based in Alexandria, VA. The CEO of the company is Mary Woolley. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
NEA Management Co. LLC
 NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
The Broad Institute, Inc.
 The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| Colgate University | College/University | Undergraduate Degree Undergraduate Degree | |
Vtesse, Inc.
 Vtesse, Inc. BiotechnologyHealth Technology Vtesse, Inc. provides novel drugs for life-threatening rare diseases. It developed VTS-270, a modified form of cyclodextrin that has been evaluated in preclinical and clinical studies at institutes within the National Institutes of Health (NIH) to treat patients with Niemann-Pick Disease Type C (NPC). The firm is working with the NIH and other leading academic centers to advance clinical study of VTS-270 for NPC, and to conduct pre-clinical discovery and development of other novel drugs for NPC and other LSDs. The company was founded by Ben Machielse in 2015 and is headquartered in Gaithersburg, MD. | Biotechnology | Chairman Director/Board Member |
Statistics
International
| United States | 45 |
| United Kingdom | 5 |
| Ireland | 2 |
| Belgium | 2 |
Sectoral
| Health Technology | 24 |
| Consumer Services | 18 |
| Finance | 5 |
| Commercial Services | 4 |
| Process Industries | 2 |
Operational
| Director/Board Member | 649 |
| Corporate Officer/Principal | 267 |
| Independent Dir/Board Member | 208 |
| Chairman | 134 |
| Chief Executive Officer | 96 |
Most connected contacts
| Insiders | |
|---|---|
| Noubar Afeyan | 76 |
| David Mott | 45 |
| Jürgen Eckhardt | 34 |
| Ellen Marram | 33 |
| Marc M. P. de Garidel | 31 |
| Roger Pomerantz | 30 |
| Ronald Sugar | 28 |
| Dennis Fenton | 28 |
| David Pyott | 27 |
| Dennis Ausiello | 26 |
| Kevin Sharer | 24 |
| Elizabeth Anderson | 24 |
| Elaine Heron | 23 |
| Sara Nayeem | 23 |
| Wendell Wierenga | 23 |
- Stock Market
- Insiders
- Willard Dere
- Company connections
